Market Cap 1.66B
Revenue (ttm) 714.73M
Net Income (ttm) 145.49M
EPS (ttm) N/A
PE Ratio 11.63
Forward PE 10.04
Profit Margin 20.36%
Debt to Equity Ratio 0.27
Volume 399,300
Avg Vol 746,688
Day's Range N/A - N/A
Shares Out 57.35M
Stochastic %K 77%
Beta 0.80
Analysts Strong Sell
Price Target $51.78

Latest News on HRMY

Harmony Biosciences: A Compelling Risk-Reward Opportunity

Mar 24, 2025, 12:09 PM EDT - 4 weeks ago

Harmony Biosciences: A Compelling Risk-Reward Opportunity